Communiqués AngioDynamics, Inc.

Actions

ANGO

US03475V1017

Equipement, fournitures et distribution médicale

Marché Fermé - Nasdaq 22:00:00 01/09/2026			Varia. 5j.	Varia. 1 janv.
15,86 ^USD	-1,67%		-0,56%	+23,52%

14/07	Transcript : AngioDynamics, Inc., Q4 2026 Earnings Call, Jul 14, 2026
14/07	AngioDynamics, Inc. publie ses résultats pour le quatrième trimestre clos le 31 mai 2026	CI

Communiqués

28/07	AngioDynamics to Participate in Upcoming Investor Conferences	BU
14/07	AngioDynamics : Annual Report for Fiscal Year Ending May 31, 2026 (Form 10-K)	PU
14/07	AngioDynamics: Fiscal Q4 Earnings Snapshot	AQ
14/07	AngioDynamics : Press space to expand and collapse this section AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability	PU
14/07	AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability	BU
30/06	AngioDynamics to Report Fiscal 2026 Fourth Quarter and Full-Year Financial Results on July 14, 2026	BU
17/06	AngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)	BU
28/05	AngioDynamics Expands Patient Access to NanoKnife IRE for Prostate and Liver Cancer as Medicare Coverage Framework Takes Effect	BU
27/05	AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference	BU
13/05	AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer	BU
02/04	AngioDynamics : Q3 FY2026 Presentation	PU
02/04	AngioDynamics: Fiscal Q3 Earnings Snapshot	AQ
02/04	AngioDynamics Reports Fiscal Year 2026 Third Quarter Financial Results; Sustained Double-Digit Med Tech Growth Drives Continued Profitability	BU
31/03	AngioDynamics to Present at the 25th Annual Needham Virtual Healthcare Conference	BU
19/03	AngioDynamics to Report Fiscal 2026 Third Quarter Results on April 2, 2026	BU
23/02	AngioDynamics to Present at the Leerink Partners Global Healthcare Conference	BU
19/02	AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform	BU
05/02	AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care	BU
03/02	AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance	BU
06/01	AngioDynamics: Fiscal Q2 Earnings Snapshot	AQ
06/01	AngioDynamics : Q2 FY2026 Presentation	PU
06/01	AngioDynamics Reports Fiscal Year 2026 Second Quarter Financial Results; Continued Double Digit Med Tech Growth Drives Increased Profitability	BU
23/12	AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026	BU
22/12	AngioDynamics to Present at the 44th Annual J.P. Morgan Healthcare Conference	BU
27/10/25	AngioDynamics to Participate in the UBS Global Healthcare Conference	BU